TermAffirm
TermAffirm is an ultrasound-based diagnostic which identifies women at high risk for cervical insufficiency in pregnancy, and an associated patient-specific cervical pessary. TermAffirm Team: Andrew Westervelt, Founder
Read MoreDrinkSavvy
DrinkSavvy is developing colorimetric chemical sensors to detect “date rape drugs” and help consumers from ingesting them and falling prey to date rape and robbery. DrinkSavvy Team: Brendan Walker
Read MoreBioHealthWays, Inc.
BioHealthWays prevents vision loss by delivering biologics in the eye. Our implant drastically reduces injections and improves compliance & convenience. The target market is $7B+, with 12M Americans having retinal neovascular conditions.
Read MoreBioharmony Therapy
Bioharmony Therapeutics is an early-stage biotech startup focused on the development of first-in-class antimicrobials that target infections caused by Gram-negative bacteria. Bioharmony Theraputics Team: Chandrabali Ghose-Paul, Founder and CEO
Read MoreArdent
Ardent has developed technologies to transform “energy-storing” white adipose tissue (WAT) into “energy-burning” brown adipose tissue (BAT) for treatment of obesity, diabetes, and metabolic disease. Team: Luis Santos Brian Gillette
Read MoreVeripad
Veripad has created the most affordable and accessible system for checking the quality of medicines by using a paper chemical test card and companion mobile app. Team: Executive Leadership Bishoy Ghobryal, CEO Da Wi Shin, COO Y-Lan Nguyen, CAO Jason Ki, CTO
Read MoreChemitope Glycopeptide
Chemitope specializes in the chemical synthesis of complex glycopeptides for use in challenging vaccine applications, such as HIV. Team: Baptiste Aussedat, PhD William Walkowicz, PhD
Read MoreLysimmune BioScience
Platform technology to produce recombinant therapeutic antibodies against Staphylococcus aureus and other pathogens, targeting cell wall carbohydrates not adequately recognized by the human immune system. Team: Assaf Raz, PhD – CSO Vincent A. Fischetti, PhD – Head of SAB
Read MoreCatheCare
CatheCare’s CASS device uses ultraviolet light to prevent the deadly catheter-related infection. Team: Aonnicha Burapachaisr – CEO Chanond Sophonpanich – COO
Read MoreMotion2Movement
A remote knee-therapy platform that enables patient engagement, and provides critical data to clinicians including muscle activation, therapy compliance and progress, and patient-reported outcomes. Team: Ralph Hertz, President Ankush Thakur, VP Mark Hase, VP Sam Tran, VP
Read More